Canada Life
SRPT icon

Canada Life’s Sarepta Therapeutics SRPT Stock Holding History

Canada Life’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.85M Sell
85,195
-4,024
-5% -$77.9K ﹤0.01% 1178
2025
Q4 		$1.92M Sell
89,219
-7,822
-8% -$165K ﹤0.01% 1178
2025
Q3 		$1.83M Buy
97,041
+25,508
+36% +$455K ﹤0.01% 1262
2025
Q2 		$1.22M Buy
71,533
+1,769
+3% +$75.5K ﹤0.01% 1369
2025
Q1 		$4.45M Sell
69,764
-6,179
-8% -$650K 0.01% 836
2024
Q4 		$9.22M Sell
75,943
-503
-0.7% -$61.6K 0.02% 588
2024
Q3 		$9.55M Buy
76,446
+5,440
+8% +$752K 0.02% 593
2024
Q2 		$11.2M Buy
71,006
+47,639
+204% +$6.12M 0.02% 527
2024
Q1 		$3.02M Sell
23,367
-1,681
-7% -$206K 0.01% 1052
2023
Q4 		$2.4M Buy
25,048
+2,467
+11% +$237K 0.01% 1154
2023
Q3 		$2.74M Buy
22,581
+2,986
+15% +$337K 0.01% 1028
2023
Q2 		$2.26M Buy
19,595
+1,319
+7% +$170K 0.01% 1141
2023
Q1 		$2.52M Sell
18,276
-913
-5% -$118K 0.01% 1122
2022
Q4 		$2.5M Buy
19,189
+8,415
+78% +$975K 0.01% 1120
2022
Q3 		$1.19M Buy
10,774
+6,011
+126% +$606K ﹤0.01% 1420
2022
Q2 		$357K Buy
4,763
+222
+5% +$16.3K ﹤0.01% 1736
2022
Q1 		$377K Buy
4,541
+281
+7% +$21.5K ﹤0.01% 1772
2021
Q4 		$382K Buy
4,260
+92
+2% +$7.87K ﹤0.01% 1755
2021
Q3 		$387K Sell
4,168
-12,246
-75% -$943K ﹤0.01% 1779
2021
Q2 		$1.27M Sell
16,414
-37,306
-69% -$2.83M ﹤0.01% 1399
2021
Q1 		$3.98M Buy
53,720
+4,556
+9% +$420K 0.01% 778
2020
Q4 		$8.35M Buy
49,164
+10,596
+27% +$1.57M 0.02% 665
2020
Q3 		$5.42M Buy
38,568
+10,871
+39% +$1.65M 0.01% 690
2020
Q2 		$4.42M Buy
27,697
+8,285
+43% +$1.13M 0.01% 726
2020
Q1 		$1.91M Buy
19,412
+664
+4% +$75.9K 0.01% 972
2019
Q4 		$2.4M Buy
+18,748
New +$1.89M 0.01% 1014
2019
Q3 		– Sell
-8,438
Closed -$1.28M – 2120
2019
Q2 		$1.28M Sell
8,438
-136
-2% -$16.5K ﹤0.01% 1415
2019
Q1 		$1.02M Buy
8,574
+1,098
+15% +$141K ﹤0.01% 1374
2018
Q4 		$787K Buy
7,476
+528
+8% +$66K ﹤0.01% 1502
2018
Q3 		$1.12M Hold
6,948
– – ﹤0.01% 1472
2018
Q2 		$918K Hold
6,948
– – ﹤0.01% 1563
2018
Q1 		$516K Sell
6,948
-1,572
-18% -$105K ﹤0.01% 1727
2017
Q4 		$473K Buy
8,520
+2,111
+33% +$112K ﹤0.01% 1749
2017
Q3 		$301K Buy
6,409
+1,474
+30% +$58.9K ﹤0.01% 1846
2017
Q2 		$166K Hold
4,935
– – ﹤0.01% 1963
2017
Q1 		$146K Hold
4,935
– – ﹤0.01% 1991
2016
Q4 		$136K Hold
4,935
– – ﹤0.01% 2018
2016
Q3 		$303K Hold
4,935
– – ﹤0.01% 1800
2016
Q2 		$94K Hold
4,935
– – ﹤0.01% 2119
2016
Q1 		$96K Hold
4,935
– – ﹤0.01% 1820
2015
Q4 		$191K Hold
4,935
– – ﹤0.01% 1309
2015
Q3 		$159K Buy
4,935
+2,700
+121% +$91.6K ﹤0.01% 1379
2015
Q2 		$68K Hold
2,235
– – ﹤0.01% 2078
2015
Q1 		$30K Hold
2,235
– – ﹤0.01% 2254
2014
Q4 		$32K Hold
2,235
– – ﹤0.01% 2244
2014
Q3 		$47K Hold
2,235
– – ﹤0.01% 2064
2014
Q2 		$66K Hold
2,235
– – ﹤0.01% 1815
2014
Q1 		$53K Hold
2,235
– – ﹤0.01% 1758
2013
Q4 		$46K Buy
+2,235
New +$66.4K ﹤0.01% 1833

Other funds holding SRPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Canada Life's SRPT Position: Q1 2026 in Review

Canada Life reduced its Sarepta Therapeutics (SRPT) stake by 4.5% in Q1 2026, selling an estimated $77.9K and leaving 85,195 shares worth $1.85M. The position accounts for ﹤0.01% of the portfolio, ranked #1178.

Canada Life first reported a position in SRPT in Q4 2013 and has held it in 49 quarters since. The position peaked at $11.2M in Q2 2024. 339 funds tracked by Wall St. Rank hold SRPT as of Q1 2026.

  • Canada Life held 85,195 shares of Sarepta Therapeutics worth $1.85M as of Q1 2026.
  • Canada Life sold 4,024 Sarepta Therapeutics shares in Q1 2026, an estimated $77.9K.
  • Sarepta Therapeutics made up ﹤0.01% of Canada Life's portfolio in Q1 2026, its #1178 holding.
  • Canada Life first reported a position in Sarepta Therapeutics in Q4 2013 and has held it in 49 quarters since.
  • Canada Life's Sarepta Therapeutics position peaked at $11.2M in Q2 2024.
  • 339 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q1 2026.

Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.